Dopamine D1-like receptors and reward-related incentive learning

Neuroscience and Biobehavioral Reviews

Volumn 22, Issue 2, 1998, Pages 335-345

  Beninger, Richard J ^a   Miller, Robert ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

CAMP; D1; D2; Dopamine; Incentive; Learning; Plasticity; Protein kinase; Reward; Striatum

Indexed keywords

1 (2 BROMO 4,5 DIMETHOXYBENZYL) 1,2,3,4 TETRAHYDRO 7 HYDROXY 6 METHOXY 2 METHYLISOQUINOLINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 2,3,4,5 TETRAHYDRO 1 PHENYL 1H 3 BENZAZEPINE 7,8 DIOL; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; BROMOCRIPTINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; METOCLOPRAMIDE; N (3 HYDROXYPHENETHYL) N (PHENETHYL)PROPYLAMINE; PIMOZIDE; PIRIBEDIL; RACLOPRIDE; ROTIGOTINE; SKF 75760; SPIPERONE; SULPIRIDE; UNCLASSIFIED DRUG;

APLYSIA; BRAIN DEPTH STIMULATION; DOPAMINERGIC NERVE CELL; FOOD; HUMAN; INSTRUMENTAL CONDITIONING; LEARNING; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; REWARD; SCHIZOPHRENIA; SECOND MESSENGER;

EID: 0031897943     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(97)00019-5     Document Type: Article

References (127)

1. Acquas E., DiChiara G. D1 receptor blockade stereospecifically impairs the acquisition of drug-conditioned place preference and place aversion. Behav. Pharmacol. 5:1994;555-569.
2. Agmo A., Federman I., Navarro V., Padua M., Velazquez G. Reward and reinforcement produced by drinking water: Role of opioids and dopamine receptor subtypes. Pharmacol. Biochem. Behav. 46:1993;183-194.
3. Beninger R.J. The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6:1983;173-196.
4. Beninger, R.J. Role of D1 and D2 receptors in learning. In: Waddington, J., ed. D1, D2 Dopamine receptor interactions: Neuroscience and pharmacology. London: Academic Press; 1993: 115-157.
5. Beninger R.J., Hoffman D.C., Mazurski E.J. Receptor subtype-specific dopaminergic agents and conditioned behavior. Neurosci. Biobehav. Rev. 13:1989;113-122.
6. Beninger, R.J.; Nakonechny, P.L. Dopamine D1-like receptors and molecular mechanisms of incentive learning. In: Beninger, R.J.; Palomo, T.; Archer, T., eds. Dopamine disease states. Madrid: CYM Press; 1996:407-431.
7. Beninger R.J., Ranaldi R. The effects of amphetamine, apomorphine, SKF 38393, quinpirole and bromocriptine on responding for conditioned reward in rats. Behav. Pharmacol. 3:1992;155-163.
8. Beninger, R.J.; Ranaldi, R. Dopaminergic agents with different mechanisms of action differentially affect responding for conditioned reward. In: Palomo, T.; Archer, T., eds. Strategies for studying brain disorders: Vol 1. Depressive, anxiety and drug abuse disorders. London: Farrand Press; 1994: 411-428.
9. Beninger R.J., Rolfe N.G. Dopamine D1-like receptor agonists impair responding for conditioned reward in rats. Behav. Pharmacol. 6:1995;785-793.
10. Bergman J., Rosenzweig-Lipson S., Spealman R.D. Differential effects of dopamine D-1 and D-2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J. Pharmacol. Exp. Therap. 273:1995;40-48.
11. Bindra D. A motivational view of learning, performance and behavior modification. Psychol. Rev. 81:1974;199-213.
12. Bindra D. How adaptive behavior is produced: A perceptual-motivational alternative to response-reinforcement. Behav. Brain Sci. 1:1978;41-91.
13. Blackstone C., Murphy T.H., Moss S.J., Baraban J.M., Huganir R.L. Cyclic AMP and synaptic activity-dependent phosphorylation of AMPA-preferring glutamate receptors. J. Neurosci. 14:1994;7585-7593.
14. Bolles R.C. Reinforcement, expectancy, and learning. Psychol. Rev. 79:1972;394-407.
15. Caine S.B., Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcemet in the rat. J. Pharmacol. Exp. Therap. 270:1994;209-218.
16. Carboni E., Imperto A., Perezzani L., DiChiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neurosci. 28:1989;653-663.
17. Carey R.J. Bromocriptine promotes recovery of self-stimulation in 6-hydroxydopamine-lesioned rats. Pharmacol. Biochem. Behav. 18:1983;273-276.
18. Casey D.E. Neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacol. 99(Suppl):1989;S47-S53.
19. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition of cocaine conditioning place preference. Brain Res. 673:1995;242-250.
20. Chaperon F., Thiébot M.-H. Effects of dopaminergic D3-receptor-preferring ligands on the acquisition of place conditioning in rats. Behav. Pharmacol. 7:1996;105-109.
21. Civelli O., Bunzow J.R., Grandy D.K. Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 32:1993;281-307.
22. Colwell C.S., Levine M.S. Excitatory synaptic transmission in neostriatal neurons: Regulation by cyclic AMP-dependent mechanisms. J. Neurosci. 15:1995;1704-1713.
23. Davies J.A., Jackson B., Redfern P.H. The effect of amantadine, L-DOPA, (+)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response. Neuropharmacol. 13:1974;199-204.
24. Davis H.P., Squire L.R. Protein synthesis and memory: A review. Psychol. Bull. 96:1984;518-559.
25. DeZazzo J., Tully T. Dissection of memory formation: From behavioral pharmacology to molecular genetics. Trends Neurosci. 18:1995;212-217.
26. Drain P., Folkers E., Quinn W.G. cAMP-dependent protein kinase and the disruption of learning in transgenic flies. Neuron. 6:1991;71-82.
27. Fowler S.C., Liou J.-R. Microcatalepsy and disruption of forelimb usage during operant behavior: Differences between dopamine D1 (SCH-23390) and D2 (raclopride) antagonists. Psychopharmacol. 115:1994;24-30.
28. Frey U., Huang Y.-Y., Kandel E.R. Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science. 260:1993;1661-1664.
29. Garris P.A., Ciolkowski E.L., Pastore P., Wightman R.M. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14:1994;6084-6093.
30. Gonon F.G., Buda M.J. Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neurosci. 14:1985;765-774.
31. Grebb, J.A. Protein phosphorylation in the nervous system: Possible relevance to schizophrenia research. In: Nakazawa, T., ed. The biological basis of schizophrenic disorders. Tokyo: Japanese Scientific Societies Press; 1991:77-89.
32. Greengard P., Jen J., Nairn A.C., Stevens C.F. Enhancement of the glutamate response by c-AMP-dependent protein kinase in hippocampal neurons. Science. 253:1991;1135-1138.
33. Hebb, D.O. The organization of behavior: A neurophysiological theory. New York: John Wiley; 1949.
34. Hegde A.N., Goldberg A.L., Schwartz J.H. Regulatory subunits of cAMP-dependent protein kinases are degraded after conjugation to ubiquitin: A molecular mechanism underlying long-term plasticity. Proc. Natl Acad. Sci. USA. 90:1993;7436-7440.
35. Hemmings H.C. Jr., Walaas S.I., Ouimet C.C., Greengard P. Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32. Trends Neurosci. 10:1987;377-383.
36. Herberg L.J., Stephens D.N., Franklin K.B.J. Catecholamines and self-stimulation: Evidence suggesting a reinforcing role for noradrenaline and a motivating role for dopamine. Pharmacol. Biochem. Behav. 4:1976;575-582.
37. Hiroi N., White N.M. The amphetamine conditioned place preference - Differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 552:1991;141-152.
38. Hoffman D.C., Beninger R.J. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning. Pharmacol. Biochem. Behav. 31:1988;1-8.
39. Hoffman D.C., Beninger R.J. Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats. Pharmacol. Biochem. Behav. 34:1989;923-925.
40. Hoffman D.C., Beninger R.J. The effects of selective dopamine D1 and D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats. Pharmacol. Biochem. Behav. 33:1989;273-279.
41. Hoffman D.C., Dickson P.R., Beninger R.J. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12:1988;315-322.
42. Huang Y.Y., Kandel E.R. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc. Natl Acad. Sci. USA. 92:1995;2446-2493.
43. Hunt G.E., Atrens D.M., Jackson D.M. Reward summation and the effects of dopamine D-1 and D-2 agonists and antagonists on fixed-interval responding for brain stimulation. Pharmacol. Biochem. Behav. 48:1994;853-862.
44. Hurd Y.L., Ungerstedt U. Ca2+-dependence of the amphetamine, nomifensine, and Lu-19-005 effect on in vivo dopamine transmission. Eur. J. Pharmacol. 166:1989;261-269.
45. Josselyn, S.A., Miller, R.J. and Beninger, R.J., Behavioral effects of clozapine and dopamine receptor subtypes. Neurosci. Biobehav. Rev., 1997.
46. Kaang B.-K., Kandel E.R., Grant S.G.N. Activation of cAMP-responsive genes by stimuli that produce long-term facilitation in aplysia sensory neurons. Neuron. 10:1993;427-435.
47. Kahn, R.S.; Davis, K.L. New developments in dopamine and schizophrenia. In: Bloom, F.E.; Kupfer, D.J., eds. Psychopharmacology: The fourth generation of progress. New York: Raven Press; 1995: 1193-1203.
48. Kandel, E.R. Cellular mechanisms of learning and the biological basis of individuality. In: Kandel, E.R.; Schwartz, J.H.; Jessell, T.M., eds. Principles of neural science. Norwalk: Appleton and Lange; 1991: 1009-1031.
49. Kandel E.R., Abel T. Neuropeptides, adenylyl cyclase, and memory storage. Science. 268:1995;825-826.
50. Katz J.L., Alling K., Shores E., Witkin J.M. Effects of D1 dopamine agonists on schedule-controlled behavior in the squirrel monkey. Behav. Pharmacol. 6:1995;143-148.
51. Katz J.L., Witkin J.M. Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacol. 109:1992;241-244.
52. Katz J.L., Witkin J.M. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey. Psychopharmacol. 113:1993;19-25.
53. Kawagoe K.T., Garris P.A., Weidemann D.J., Wightman R.M. Regulation of transient dopamine cocentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neurosci. 51:1992;55-64.
54. Kleven D.S., Woolverton W.L. Effects of continuous infusions of SCH 23390 on cocaine- or food-maintained behavior in rhesus monkeys. Behav. Pharmacol. 1:1990;365-374.
55. Knapp C.M., Kornetsky C. Bromocriptine, a D-2 receptor agonist, lowers the threshold for rewarding brain stimulation. Pharmacol. Biochem. Behav. 49:1994;901-904.
56. Konradi C., Cole R.L., Heckers S., Hyman S.E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14:1994;5623-5634.
57. Koob G.F., Le H.T., Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
58. Kuba K., Kumamoto E. Long-term potentiations in vertebrate synapses: A variety of cascades with common subprocesses. Prog. Neurobiol. 34:1990;197-269.
59. Kötter R. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44:1994;163-196.
60. Leone P., Di Chiara G. Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 135:1987;251-254.
61. Levine M.S., Altemus K.L., Cepeda C., Cromwell H.C., Crawford C., Ariano M.A., Drago J., Sibley D.R., Westphal H. Modulatory action of dopamine on NMDA receptor mediated responses are reduced in D1a-deficient mutant mice. J. Neurosci. 15:1996;5870-5882.
62. Mallet P.E., Beninger R.J. 7-OH-DPAT produces place conditioning in rats. Eur. J. Pharmacol. 261:1994;5-6.
63. McDougall S.A., Crawford C.A., Nonneman A.J. Reinforced responding of the 11-day-old rat pup - Synergistic interaction of D1 and D2 receptors. Pharmacol. Biochem. Behav. 42:1992;163-168.
64. McDougall S.A., Nonneman A.J., Crawford C.A. Effects of SCH-23390 and sulpiride on the reinforced responding of the young rat. Behav. Neurosci. 105:1991;740-744.
65. Miller, R. Meaning and purpose in the intact brain. Oxford: Clarendon Press; 1981.
66. Miller R. Major psychosis and dopamine: Controversial features and some suggestions. Psychol. Med. 14:1984;779-789.
67. Miller R. The time course of neuroleptic therapy for psychosis: Role of learning processes amd implications for concepts of psychotic illness. Psychopharmacol. 92:1987;405-415.
68. Miller R. Striatal dopamine in reward and attention: A system for understanding the symptomatology of acute schizophrenia and mania. Internat. Rev. Neurobiol. 35:1993;161-278.
69. Miller R., Chouinard G. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refectory schizophrenia. Biol. Psychiat. 34:1993;713-738.
70. Miller R., Wickens J.R., Beninger R.J. Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Prog. Neurobiol. 34:1990;143-183.
71. Mirenowicz J., Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature. 369:1996;449-450.
72. Miserendino M.J.D., Nestler E.J. Behavioral sensitization to cocaine: Modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. 674:1995;299-306.
73. Morency M.A., Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399:1986;33-41.
74. Nakajima S. Suppression of operant responding in the rat by dopamine D1 receptor blockade with SCH 23390. Physiol. Psychol. 14:1986;111-114.
75. Nakajima S., Baker J.D. Effects of D2 dopamine receptor blockade with raclopride on intracranial self-stimulation and food-reinforced operant behavior. Psychopharmacol. 98:1989;330-333.
76. Nakajima S., Liu X., Lau C.L. Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Behav. Neurosci. 107:1993;161-165.
77. Nakajima S., O'Regan N.B. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat. Pharmacol. Biochem. Behav. 39:1991;465-468.
78. Nakonechny, P.L. The effect of microinjections of the protein kinase inhibitor Rp-cAMPS into the nucleus acumbens of rats: A conditioned place preference study. M.A. Thesis, Queen's Univ., 1996.
79. Nestler E.J. Molecular neurobiology of drug addiction. Neuropsychopharmacol. 11:1994;77-87.
80. Nestler E.J., Hope B.T., Widnell K.L. Drug addiction: A model for the molecular basis of neural plasticity. Neuron. 11:1993;995-1006.
81. Niznik H.B., Van Tol H.H.M. Dopamine receptor genes: New tools for molecular psychiatry. J. Psychiat. Neurosci. 17:1992;158-180.
82. Olivier V., Guibert B., Leviel V. Direct in vivo comparison of two mechanisms releasing dopamine in the rat striatum. Brain Res. 695:1995;109-115.
83. Ranaldi R., Beninger R.J. Dopamine D1 and D2 antagonists attenuate amphetamine-produced enhancement of responding for conditioned reward in rats. Psychopharmacol. 113:1993;110-118.
84. Ranaldi R., Beninger R.J. The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward. Brain Res. 651:1994;283-292.
85. Ranaldi R., Beninger R.J. Bromocriptine enhancement of responding for conditioned reward depends on intact D1 receptor function. Psychopharmacol. 118:1995;437-443.
86. Ranaldi R., Pantalony D., Beninger R.J. The D1 agonist SKF 38393 attenuates amphetamine-produced enhancement of responding for conditioned reward in rats. Pharmacol. Biochem. Behav. 52:1995;131-137.
87. Robbins T.W., Everitt B.J. Functional studies of the central catechlolamines. Internat. Rev. Neurobiol. 23:1982;303-365.
88. Robbins T.W., Watson B.A., Gaskin M., Ennis C. Contrasting interactions of pipradol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacol. 80:1983;113-119.
89. Rusk I.N., Cooper S.J. Profile of the selective dopamine D-2 receptor agonist N-0437: Its effects on palatability- and deprivation-induced feeding, and operant responding for food. Physiol. Behav. 44:1988;545-553.
90. Rusk I.N., Cooper S.J. The selective dopamine D1 receptor agonist SK and F 38393: Its effects on palatability- and deprivation-induced feeding, and operant responding for food. Pharmacol. Biochem. Behav. 34:1989;43-49.
91. Schultz W. Activity of dopamine neurons in the behaving primate. Semin. Neurosci. 4:1992;129-138.
92. Schultz W., Apicella P., Ljungberg T. Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J. Neurosci. 13:1993;900-913.
93. Schultz W., Apicella P., Scarnati E., Ljungberg T. Neuronal activity in monkey ventral striatum related to the expectation of reward. J. Neurosci. 12:1992;4594-4610.
94. Self, D.W.; Lam, D.M.; Kossuth, S.R.; Stein, L. Effects of D1 and D2-selective antagonists on self-administration of the D1 agonist SKF 82958. In: Harris, L., ed. NIDA research monograph 132, College on the problems of drug dependence. Washington: NIDA; 1993: 230.
95. Self D.W., Stein L. The D1 agonists SKF-82958 and SKF-77434 are self-administered by rats. Brain Res. 582:1992;349-352.
96. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: Role of the mesolimbc dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Therap. 265:1993;53-59.
97. Shippenberg T.S., Balskubik R., Huber A., Herz A. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacol. 103:1991;200-209.
98. Shippenberg T.S., Hertz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and k-opioid agonists. Brain Res. 436:1987;169-172.
99. Shippenberg T.S., Herz A. Motivational effects of opioids: Influence of D-1 versus D-2 receptor antagonists. Eur. J. Pharmacol. 151:1988;233-243.
100. Sibley, D.R.; Monsma, F.J.,Jr.; Shen, Y. Molecular neurobiology of D1 and D2 dopamine receptors. In: Waddington, J., ed. D1: D2 Dopamine Receptor Interactions. London: Academic Press; 1993: 1-17.
101. Skoulakis E.M.C., Kalderon D., Davis R.L. Preferential expression in mushroom bodies of the catalytic subunit of protein kinase A and its role in learning and memory. Neuron. 11:1993;197-208.
102. Spatz H.C. Postranslational modification of protein kinase A. The link between short-term and long-term memory. Behav. Brain Res. 66:1995;79-84.
103. Stein L., Belluzzi J.D. Cellular investigations of behavioral reinforcement. Neurosci. Biobehav. Rev. 13:1989;69-80.
104. Stein L., Xue B.G., Belluzzi J.D. A cellular analog of operant conditioning. J. Exp. Anal. Behav. 60:1993;41-53.
105. Stein L., Xue B.G., Belluzzi J.D. In vitro reinforcement of hippocampal bursting: A search for Skinner's atoms of behavior. J. Exp. Anal. Behav. 61:1994;155-168.
106. Stewart, J. Conditioned stimulus control of expression of sensitization of the behavioral activating effects of opiate and stimulant drugs. In: Gormezano, I.; Wasserman, E.A., eds. Learning and memory: Behavioral and biological substrates. Hillsdale: Lawrence Erlbaum Publishers; 1992: 129-151.
107. Stewart, J.; Vezina, P. Conditioning and behavioral sensitization. In: Kalivas, P.W.; Barnes, C.D., eds. Sensitization in the nervous system. Caldwell: Telford Press; 1988: 207-224.
108. Stewart J., Vezina P. Microinjections of SCH-23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495:1989;401-406.
109. Sunahara R.K., Seeman P., Van Tol H.H.M., Niznik H.B. Dopamine receptors and antipsychotic drug response. Br. J. Psychiatr. 163:1993;31-38.
110. Terry P., Katz J.L. Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat. Psychopharmacol. 109:1992;403-409.
111. Tidey J.W., Miczek K.A. Effects of SKF 38393 and quinpirole on aggressive, motor and schedule-controlled behaviors in mice. Behav. Pharmacol. 3:1992;553-566.
112. Vezina P., Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499:1989;108-121.
113. Wang L.Y., Salter M.W., MacDonald J.F. Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science. 1132:1991;1132-1135.
114. Wang L.Y., Taverna F.A., Huang X.-P., MacDonald J.F., Hampson D.R. Phosphorylation and modulation of a kainate receptor (GLuR6) by cAMP-dependent protein kianse. Science. 259:1993;1173-1175.
115. Weed M.R., Vanover K.E., Woolverton W.L. Reinforcing effect of the D1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacol. 113:1993;51-52.
116. Westerink B.H.C., Tuntler J., Damsma G., Rollema H., De Vries J.B. The use of tetrodotoxin for the characterizartion of drug-induced dopamine release in conscious rats studied by brain dialysis. Nauny. Schmied. Arch. Pharmacol. 336:1987;502-507.
117. White N.M., Hiroi N. Pipradrol conditioned place preference is blocked by SCH23390. Pharmacol. Biochem. Behav. 43:1992;377-380.
118. White N.M., Packard M.G., Hiroi N. Place conditioning with dopamine - D1 and D2 agonists induced peripherally or into nucleus accumbens. Psychopharmacol. 103:1991;270-276.
119. Wickens J. Striatal dopamine in motor activation and reward-mediated learning: Steps towards a unifying model. J. Neural Transm. 80:1990;9-31.
120. Wickens, J. A theory of the striatum. Oxford: Pergamon Press; 1993.
121. Wickens, J.; Kötter, R. Cellular models of reinforcement. In: Houk, J.C.; Davis, J; Beiser, D.G., eds. Models of information processing in the basal ganglia. Cambridge: MIT Press; 1995: 187-214.
122. Wickens J.R., Begg A.J., Arbuthnott G.W. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex in vitro. Neurosci. 70:1996;1-6.
123. Wise R.A., Murray A., Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacol. 100:1990;355-361.
124. Wise R.A., Rompré P.-R. Brain dopamine and reward. Ann. Rev. Psychol. 40:1989;191-227.
125. Witkin J.M., Schindler C.W., Tella S.R., Goldberg S.R. Interaction of haloperidol and SCH-23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys. Psychopharmacol. 104:1991;420-431.
126. Woolverton W.L. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24:1986;531-536g.
127. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Therap. 230:1984;678-683.